DGX

AI Research

CEO transition + dividend up 7.5% → Q4 net revenues $2.81B (+7.1%); $1B buyback authorized

Quest Diagnostics reported Q4 2025 net revenues of $2.81 billion (+7.1%), with 2026 guidance of $11.70-$11.82B revenue and $10.50-$10.70 adjusted diluted EPS. CEO Jennifer Erickson took over with a 7.5% dividend increase to $0.86 per share from $0.80 and a $1B share buyback authorization. The company was named to Fortune's 2026 Most Admired Companies list for the 12th consecutive year.